Chapters

Transcript

Video

Adjuvant Palbociclib in HR+/HER2 Early Breast Cancer - Final results from PALLAS Trial

Dana-Farber's Erica Mayer, MD, MPH discusses the final analysis of the International Phase 3 PALLAS clinical trial presented at the 2021 San Antonio Breast Cancer Symposium.


Published

December 8, 2021

Created by

Dana-Farber

Related Presenters

Erica Mayer, MD, MPH

Erica Mayer, MD, MPH

Institute Physician
Assistant Professor of Medicine, Harvard Medical School

Dr. Mayer is a medical oncologist and clinical investigator in the Breast Oncology Center.

View full profile